What is the address of BioConAct?

The registered office of BioConAct is located at Kurs 6, 9831 Sint-Martens-Latem.

Is BioConAct still active?

Yes. According to the CBE (2 November 2026) BioConAct is active, legal situation “Normale toestand”, started on 9 April 2020.

Is BioConAct registered on Peppol?

Yes, BioConAct is registered on the Peppol network with ID 0208:0745917924.

What is the enterprise number of BioConAct?

The enterprise number of BioConAct is BE0745917924.

When was BioConAct founded?

BioConAct was founded on 9 April 2020.

Who are the directors of BioConAct?

According to the 2025 annual accounts, the directors of BioConAct are: Katrien Vanhonacker.

Is BioConAct a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 9 April 2020; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account; 1 events from the Belgian Official Gazette processed.

How much profit did BioConAct make in 2025?

BioConAct posted a profit after taxes of € 44,246 in financial year 2025.

What is the revenue of BioConAct?

As a small company, BioConAct is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 36,693.

BioConAct (Private Limited) - Sint-Martens-Latem

Q: What does BioConAct do?

BioConAct is registered with the CBE as active in: Activiteiten van adviesbureaus op het gebied van public relations en communicatie. Private Limited, started on 9 April 2020, 1 establishment.

Dossier BioConAct, printed on 3 November 2026 from databakkes.be/en/0745917924/bioconact. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Tight liquidity NBB

Cash and receivables cover 46 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

BioConAct from Sint-Martens-Latem, company number BE0745917924, closed financial year 2025 with a result of € 44,246 after tax. For that financial year BioConAct recorded a gross margin of € 36,693 and equity of € 44,346. Compared with financial year 2024, the result moved from € 21,495 to € 44,246. Profitable, and profit is growing. The company holds a healthy buffer. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on September 15, 2026.

What it is worth Healthy

€ 44,346

▼ 13% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 44,246

▲ 106% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 7,835

▼ 60% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 50,998 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Vehicles and equipment

€ 1,155

▼ 25% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 6,777

▼ 52% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 20,620

▼ 45% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 41,336 Gross margin 2022: € 41,336 First fiscal year in the series	€ 54,264 Gross margin 2023: € 54,264 ▲ 31% vs 2022 (€ 41,336) Favourable step	€ 30,574 Gross margin 2024: € 30,574 ▼ 44% vs 2023 (€ 54,264) Unfavourable step	€ 36,693 Gross margin 2025: € 36,693 ▲ 20% vs 2024 (€ 30,574) Favourable step	▲ 20%
Profit after taxes	€ 32,050 Profit after taxes 2022: € 32,050 First fiscal year in the series	€ 29,503 Profit after taxes 2023: € 29,503 ▼ 8% vs 2022 (€ 32,050) Unfavourable step	€ 21,495 Profit after taxes 2024: € 21,495 ▼ 27% vs 2023 (€ 29,503) Unfavourable step	€ 44,246 Profit after taxes 2025: € 44,246 ▲ 106% vs 2024 (€ 21,495) Favourable step	▲ 106%
Equity	€ 80,638 Equity 2022: € 80,638 First fiscal year in the series	€ 110,141 Equity 2023: € 110,141 ▲ 37% vs 2022 (€ 80,638) Favourable step	€ 51,098 Equity 2024: € 51,098 ▼ 54% vs 2023 (€ 110,141) Unfavourable step	€ 44,346 Equity 2025: € 44,346 ▼ 13% vs 2024 (€ 51,098) Unfavourable step	▼ 13%
Total debts	€ 29,442 Total debts 2022: € 29,442 First fiscal year in the series	€ 32,307 Total debts 2023: € 32,307 ▲ 10% vs 2022 (€ 29,442) Unfavourable step	€ 120,206 Total debts 2024: € 120,206 ▲ 272% vs 2023 (€ 32,307) Unfavourable step	€ 131,972 Total debts 2025: € 131,972 ▲ 10% vs 2024 (€ 120,206) Unfavourable step	▲ 10%
Cash	€ 67,210 Cash 2022: € 67,210 First fiscal year in the series	€ 24,277 Cash 2023: € 24,277 ▼ 64% vs 2022 (€ 67,210) Unfavourable step	€ 19,811 Cash 2024: € 19,811 ▼ 18% vs 2023 (€ 24,277) Unfavourable step	€ 7,835 Cash 2025: € 7,835 ▼ 60% vs 2024 (€ 19,811) Unfavourable step	▼ 60%
Retained profit	€ 80,538 Retained profit 2022: € 80,538 First fiscal year in the series	€ 110,041 Retained profit 2023: € 110,041 ▲ 37% vs 2022 (€ 80,538) Favourable step	€ 50,998 Retained profit 2024: € 50,998 ▼ 54% vs 2023 (€ 110,041) Unfavourable step	€ 44,246 Retained profit 2025: € 44,246 ▼ 13% vs 2024 (€ 50,998) Unfavourable step	▼ 13%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 80,538 Dividend 2024: € 80,538 Unchanged (€ 0) Unchanged	€ 50,998 Dividend 2025: € 50,998 ▼ 37% vs 2024 (€ 80,538) Unchanged	▼ 37%
Balance sheet total	€ 110,080 Balance sheet total 2022: € 110,080 First fiscal year in the series	€ 142,448 Balance sheet total 2023: € 142,448 ▲ 29% vs 2022 (€ 110,080) Unchanged	€ 171,304 Balance sheet total 2024: € 171,304 ▲ 20% vs 2023 (€ 142,448) Unchanged	€ 176,317 Balance sheet total 2025: € 176,317 ▲ 3% vs 2024 (€ 171,304) Unchanged	▲ 3%

Key figures of BioConAct, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to BioConAct?

What happened at BioConAct in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Sep 15, 2026 New annual accounts for financial year 2025: profit of € 44,246 (▲ 106% vs 2024). filed late Source: NBB ↗
Apr 14, 2020 Incorporation, published in the Gazette. Source: Staatsblad ↗
Apr 9, 2020 New establishment in Sint-Martens-Latem. KBO

In short

From € 32,050 profit in 2022 to € 44,246 profit in 2025.

Paid € 48,848 in corporate taxes since 2022.

Best year ever: 2025, with € 44,246 profit.

Paid out € 131,536 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Katrien Vanhonacker

BioConAct

MyCellHub

@DVisory Consultants

Behind BioConAct is Katrien Vanhonacker. Katrien Vanhonacker is also behind MyCellHub and @DVisory Consultants.

Directors

According to the 2025 annual accounts

Katrien Vanhonacker

Director

Also active at: MyCellHub, @DVisory Consultants

Establishments

Establishment units

Physical locations of this company

Registered office

Kurs 6

9831 Sint-Martens-Latem

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.

All companies at this address →

AAA Consultants

@DVisory Consultants same network

€ 123,852 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Shareholders according to the Official Gazette deeds

Who contributed at incorporation and at capital increases, with the deed as source. Later share transfers are not published in the Gazette.

Incorporation

14 April 2020 Source: Deed ↗

VANHONACKER Katrien Cécile Wilfrieda(oprichter) 100%

Details

Company number

0745.917.924

VAT number

BE 0745.917.924

Registered office

Kurs 6, 9831 Sint-Martens-Latem

Names & denominations

BioConAct

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

9 April 2020

Peppol

Active · Active since 18 Nov 2025

Activities · NACE

Activiteiten van adviesbureaus op het gebied van public relations en communicatie

Adviesbureaus op het gebied van public relations en communicatie

Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies

Overige activiteiten van vrije beroepen en andere wetenschappelijke en technische activiteiten, neg

Overige vormen van onderwijs

Overige technische testen en toetsen

Speur- en ontwikkelingswerk op het gebied van de maatschappij- en geesteswetenschappen

Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering

View on CBE Public ↗ Annual accounts (NBB) ↗

BioConAct

Warning lights

Financials

What happened to BioConAct?

Management

Directors

Establishments

Establishment units

Who else lives here?

Shareholders according to the Official Gazette deeds

Details

Frequently asked questions